Humana Inc. $HUM is Pzena Investment Management LLC's 10th Largest Position

Key Points

• Pzena Investment Management LLC increased its stake in Humana Inc. by 6.5% during the 2nd quarter, making it the firm's 10th largest position in its portfolio, valued at approximately $996.66 million.
• Humana reported a Q2 EPS of $6.27, missing estimates by five cents, although its revenue rose by 9.6% year-over-year, reaching $32.39 billion.
• The company announced a quarterly dividend of $0.885 per share, set to be paid on October 31st, representing an annual yield of 1.3%.

Pzena Investment Management LLC boosted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 6.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,076,667 shares of the insurance provider's stock after acquiring an additional 247,744 shares during the quarter. Humana comprises approximately 3.3% of Pzena Investment Management LLC's portfolio, making the stock its 10th biggest holding. Pzena Investment Management LLC owned about 3.38% of Humana worth $996,664,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC raised its position in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares in the last quarter. Garde Capital Inc. purchased a new position in Humana in the first quarter worth $36,000. Zions Bancorporation National Association UT purchased a new position in Humana in the first quarter worth $37,000. Ransom Advisory Ltd purchased a new position in Humana in the first quarter worth $66,000. Finally, Rakuten Securities Inc. raised its position in Humana by 50.0% in the first quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider's stock worth $79,000 after acquiring an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HUM. Truist Financial cut their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Evercore ISI started coverage on Humana in a research report on Monday, September 22nd. They issued an "in-line" rating and a $295.00 price target for the company. Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Bank of America raised their price target on Humana from $280.00 to $300.00 and gave the company a "neutral" rating in a research report on Friday. Finally, Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $298.83.

Humana Trading Down 3.6%

Humana stock opened at $280.24 on Monday. The stock has a market cap of $33.71 billion, a PE ratio of 21.51, a P/E/G ratio of 1.64 and a beta of 0.42. The stock has a 50-day moving average price of $279.45 and a 200 day moving average price of $258.04. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.